Anebulo Pharmaceuticals Ownership | Who Owns Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals Ownership Summary

Anebulo Pharmaceuticals is owned by 55.05% institutional investors, 40.54% insiders, and 4.41% retail investors. 22nw, lp is the largest institutional shareholder, holding 59.64% of ANEB shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 0.29% of its assets in Anebulo Pharmaceuticals shares.

ANEB Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Anebulo Pharmaceuticals	55.05%	40.54%	4.41%
Sector	Healthcare Stocks	279.42%	10.64%	-190.05%
Industry	Biotech Stocks	64.05%	10.69%	25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
22nw, lp	15.47M	59.64%	$25.99M
Nantahala capital management	3.04M	11.71%	$5.10M
Mangrove partners	2.53M	9.74%	$3.64M
Lvw advisors	632.52K	2.44%	$1.06M
Morgan stanley	399.22K	1.54%	$1.09M
Ikarian capital	157.72K	0.61%	$264.97K
Vanguard group	154.04K	0.59%	$258.78K
Geode capital management	91.34K	0.35%	$153.50K
Boothbay fund management	18.84K	0.07%	$31.64K
Blackrock funding, inc. /de	3.93K	0.02%	$6.60K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
22nw, lp	15.47M	16.39%	$25.99M
Mangrove partners	2.53M	0.40%	$3.64M
Nantahala capital management	3.04M	0.22%	$5.10M
Lvw advisors	632.52K	0.13%	$1.06M
Ikarian capital	157.72K	0.04%	$264.97K
Boothbay fund management	18.84K	0.00%	$31.64K
Morgan stanley	399.22K	0.00%	$1.09M
Tower research capital llc (trc)	3.33K	0.00%	$5.59K
Vanguard group	154.04K	-	$258.78K
Geode capital management	91.34K	-	$153.50K

Top Buyers

Holder	Shares	% Assets	Change
22nw, lp	15.47M	16.39%	10.10M
Nantahala capital management	3.04M	0.22%	2.53M
Mangrove partners	2.53M	0.40%	2.53M
Geode capital management	91.34K	-	3.55K
Tower research capital llc (trc)	3.33K	0.00%	632.00

Top Sellers

Holder	Shares	% Assets	Change
King luther capital management	-	-	-59.66K
Susquehanna group, llp	-	-	-25.25K
Lvw advisors	632.52K	0.13%	-8.52K
Ubs group	25.00	-	-738.00
Blackrock	3.76K	-	-288.00

New Positions

Holder	Shares	% Assets	Change	Value
Mangrove partners	2.53M	0.40%	2.53M	$3.64M

Sold Out

Holder	Change
Wells fargo & company/mn	-62.00
Susquehanna group, llp	-25.25K
King luther capital management	-59.66K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	18	20.00%	22,618,242	0.21%	55	0.73%	9	12.50%	4	-
Dec 31, 2024	15	15.38%	22,570,347	207.34%	87	10.85%	8	60.00%	4	33.33%
Sep 30, 2024	13	8.33%	7,343,734	0.49%	28	3.57%	5	25.00%	3	50.00%
Jun 30, 2024	12	-14.29%	7,307,778	0.02%	28	3.51%	4	-33.33%	2	-33.33%
Mar 31, 2024	14	7.69%	7,306,365	0.38%	28	3.56%	6	-14.29%	3	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	121.00K	0.29%	-
Vanguard Total Stock Mkt Idx Inv	121.00K	0.29%	-
Fidelity Extended Market Index	96.47K	0.23%	-252.00
Vanguard Institutional Extnd Mkt Idx Tr	94.95K	0.23%	1.45K
Fidelity Total Market Index	48.16K	0.12%	-
Fidelity Series Total Market Index	39.48K	0.10%	-
iShares Micro-Cap ETF	16.42K	0.04%	-
Spartan Extended Market Index Pool F	11.88K	0.03%	-
Spartan Extended Market Index Pool E	10.74K	0.03%	6.32K
Fidelity Nasdaq Composite Index	7.79K	0.02%	-

Recent Insider Transactions

Date	Name	Activity	Value
Dec 23, 2024	English Aron R.	Buy	$10.00M
Dec 17, 2021	English Aron R.	Buy	$2.63K
Dec 14, 2021	English Aron R.	Buy	$2.43K
Dec 03, 2021	English Aron R.	Buy	$26.68K
Dec 02, 2021	English Aron R.	Buy	$73.33K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-
2023 Q3	-	-

ANEB Ownership FAQ

Who Owns Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals shareholders are primarily institutional investors at 55.05%, followed by 40.54% insiders and 4.41% retail investors. The average institutional ownership in Anebulo Pharmaceuticals's industry, Biotech Stocks , is 64.05%, which Anebulo Pharmaceuticals falls below.

Who owns the most shares of Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals’s largest shareholders are 22nw, lp (15.47M shares, 59.64%), Nantahala capital management (3.04M shares, 11.71%), and Mangrove partners (2.53M shares, 9.74%). Together, they hold 81.09% of Anebulo Pharmaceuticals’s total shares outstanding.

Does Blackrock own Anebulo Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Anebulo Pharmaceuticals.

Who is Anebulo Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

22nw, lp is Anebulo Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 16.39% of its assets in 15.47M Anebulo Pharmaceuticals shares, valued at 25.99M$.

Who is the top mutual fund holder of Anebulo Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Anebulo Pharmaceuticals shares, with 0.29% of its total shares outstanding invested in 121K Anebulo Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools